Trial intelligence / Profile preview

Rivastigmine for decision-making in mild cognitive impairment

IRCT20201104049257N1Phase 3Completed

Sponsor

Tehran University of Medical Sciences

Start

Apr 2021

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1